Next-generation sequencing (NGS) applications for SARS-CoV-2 detection and surveillance

Now Available On-Demand

Your details:

Email *

* Required

First Name *

* Required

Last Name *

* Required

Job Function *

* Required

Company *

* Required

Country *

* Required

Post Code or Zip *

* Required

Would you like to be contacted by an Illumina Sales Representative regarding our COVID- related solutions?

YesNo * Required

Yes, please email me from time to time about Springer Nature programs, products or services (tick to consent). You can withdraw consent at any time by clicking on the unsubscribe link at the bottom of these emails. * Required

Yes, please contact me from time to time about the sponsor’s respective programs, products or services (tick to consent). You can withdraw consent at any time by contacting the sponsor. * Required

By registering here, you agree that we can contact you to provide you with information about this webcast and your registration details will be seen by Springer Nature and the sponsor. We will not otherwise disclose your personal data to anyone else unless we have your permission as detailed in our Privacy Policy. Terms and conditions can be viewed here. *

I Agree * Required

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)

Overview

If you've already registered, please click here to log in to the webcast

Genomics is transforming modern infectious disease testing and surveillance, and expanding our understanding of pathogen evolution, and antibiotic resistance. In turn, public health professionals are changing the methods they use to research, monitor, and prevent epidemics and pandemics of high-profile infectious diseases such as influenza, tuberculosis, Ebola, and more recently, coronavirus.

In this webcast, the speaker will review the broad applicability of NGS for responding to the SARS-CoV-2 pandemic, from initial detection and characterization of the novel coronavirus to monitoring, surveillance and diagnostic detection. Illumina NGS provides workflow and analysis solutions across the clinical and public health continuum.

Learn:

The value of genomics in the COVID-19 pandemic
How NGS can be applied to support surveillance and detection/diagnostic efforts
Information NGS can provide versus other conventional methods such as PCR

This webcast has been produced for Illumina, Inc. by Nature Research Custom Media. The sponsor retains sole responsibility for content. About this content.

Presenters

Kelly Hoon

Infectious Disease Specialist
Illumina
View Biography

Dr. Jayshan Carpen

Moderator
Springer Nature
View Biography

WorkCast Online Event & Presentation Platform